• Hospira Inc., of Lake Forest, Ill., said it entered a deal to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals Ltd., in India, for about $200 million.